HA
PFE icon

Havens Advisors’s Pfizer PFE Stock Holding History

Havens Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-70,451
Closed -$2.05M – 34
2013
Q4 		$2.05M Hold
70,451
– – 1.63% 27
2013
Q3 		$1.92M Hold
70,451
– – 1.07% 36
2013
Q2 		$1.87M Buy
+70,451
New +$1.95M 1.46% 31

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Havens Advisors's PFE Position: Q1 2014 in Review

Havens Advisors sold out of Pfizer (PFE) in Q1 2014, closing a stake of 70,451 shares — an estimated $2.05M sold.

Havens Advisors first reported a position in PFE in Q2 2013 and held it in 3 quarters. The position peaked at $2.05M in Q4 2013. 1,780 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

  • Havens Advisors reported no remaining Pfizer position as of Q1 2014 after selling out during the quarter.
  • Havens Advisors sold 70,451 Pfizer shares in Q1 2014, an estimated $2.05M.
  • Havens Advisors first reported a position in Pfizer in Q2 2013 and held it in 3 quarters.
  • Havens Advisors's Pfizer position peaked at $2.05M in Q4 2013.
  • 1,780 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on Havens Advisors's 13F filing for Q1 2014, filed 8 May 2014.